.png)
LIDDS
LIDDS: First-patient-in for docetaxel Phase I (Redeye)
2019-03-13 11:41
LIDDS today annonuced that their first patient has been enrolled in Phase I study with Nanozolid-docetaxl.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se